Pediatric Cancer Trials: US FDA Panel To Weigh Use Of Real-World Data, Patient-Reported Outcomes

 
• By Sue Sutter
  
Girl with diary
An FDA panel will discuss the utility of patient self-reporting in pediatric cancer trials. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers